Question explored with the scientific record
Healthy vaccine effect
The honest answer: the evidence on whether vaccines help healthy people is genuinely split, and the studies that look best on paper have the weakest designs.
The strongest evidence for benefit comes from a Norwegian cohort of 4.6 million adults, where fully vaccinated people had roughly 60% lower all-cause mortality than unvaccinated [2]. But the authors themselves flag the problem: healthier people are more likely to get vaccinated, and that "healthy vaccinee bias" can create the appearance of protection that isn't real [2]. A Hungarian study tried to correct for this and still found 49-75% lower mortality across six different vaccines [7], but it was observational, not a randomized trial.
The evidence against is just as substantial. UK data shows vaccinated people initially had lower mortality, but that advantage eroded over time and by late 2021 they were dying at higher rates than unvaccinated [3][6]. A US county-level analysis of over 3,000 counties found higher vaccination uptake was associated with higher excess mortality in 2022 and 2023 [4]. A Japanese study found more doses meant lower mortality in people over 65, but higher mortality in younger adults [5]. One analysis of Australian data concluded the claimed benefits were mathematically implausible [1].
| Population | Finding | Source |
|---|---|---|
| Norwegian adults, all ages | 60% lower mortality in vaccinated | [2] |
| Hungarian adults | 49-75% lower mortality, HVE-adjusted | [7] |
| UK adults | Mortality advantage reversed by late 2021 | [3][6] |
| US counties | Higher uptake, higher excess mortality | [4] |
| Japanese 20-49 | Higher mortality with 5+ doses | [5] |
The uncomfortable truth is that no randomized controlled trial has ever tested whether COVID vaccines reduce all-cause mortality in healthy people. Every study here is observational, and observational studies comparing vaccinated to unvaccinated people are structurally biased by who chooses to get vaccinated. The Norwegian and Hungarian studies tried to adjust for this; the UK and US analyses suggest the adjustment may not have been enough.
For a healthy person, the question isn't whether vaccines prevent COVID death (they clearly do for high-risk groups). It's whether the benefit outweighs the risk of harm. The evidence here cannot answer that with confidence.
My call: the evidence is genuinely conflicting, and the absence of a randomized trial means we cannot separate true benefit from healthy-vaccinee bias. Confidence: low.
Sources used 7
-
The Claim That COVID-19 Vaccination Protected Australians from All-Cause Mortality Is Not Plausible
Liu et al.'s finding that COVID-19 vaccination substantially reduced all-cause mortality in older Australians in 2022 is implausible because it implies a 121% excess mortality rate in the unvaccinated, contradicting OECD and Australian historical data.
DOI: 10.71189/jim/2026/v02n03a11 -
COVID-19 mRNA vaccination and all-cause mortality in the adult population in Norway during 2021–2023: a population-based cohort study
In a Norwegian population-based cohort of 4,645,910 adults followed from January 2021 to December 2023, individuals who received three or more mRNA vaccine doses had a substantially lower adjusted all-cause mortality rate than unvaccinated individuals, with fully vaccinated adul…
DOI: 10.1136/bmjph-2024-001859 -
All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data
The analysis of UK ONS data from April 2021 to May 2023 found that all-cause and non-COVID-19 mortality SMRs increased over time for vaccinated individuals relative to unvaccinated individuals across all age groups, with predicted crossing points from September 2022 to January 2…
DOI: 10.12688/f1000research.154058.2 -
Why COVID-19 vaccination cannot be ruled out as an explanation for all-cause excess mortality in the pandemic’s aftermath: A population-level study of over 3,000 US counties with over 320 million people
A US county-level study found positive associations between per-capita COVID-19 vaccine uptake and all-cause excess mortality in 2022 and 2023, even when adjusting for lagged mortality, but the design cannot establish causation.
DOI: 10.12688/f1000research.177279.1 -
Age-specific patterns of all-cause mortality across COVID-19 booster dose groups in two Japanese municipalities: an exploratory analysis
Exploratory analysis of Japanese municipal registry data found lower all-cause mortality among highly vaccinated adults aged 65-89 years but higher all-cause mortality among adults aged 20-49 years with ≥5 doses and those aged 50-64 with six doses, with causality unestablished.
DOI: 10.3389/fpubh.2026.1795437 -
The temporal protection and declining health of the COVID-19 vaccinated in England: A 26-month comparison of the mortality involving and not involving COVID-19 among vaccinated vs. unvaccinated
Using English monthly age-standardized mortality data from Apr 2021 to May 2023, the study finds that unvaccinated individuals had initially higher all-cause and non-COVID mortality, that vaccinated individuals showed temporary protection between Jul 2021 and Jan 2022, and that …
DOI: 10.12688/f1000research.160980.1 -
Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study
In a nationwide retrospective cohort of 6.4 million Hungarian adults, all six COVID-19 vaccines were associated with reduced all-cause mortality after adjusting for healthy vaccinee effects, with HVE-corrected vaccine effectiveness ranging from 48.7% for Pfizer-BioNTech to 75.4%…
DOI: 10.3390/vaccines10071009